INTRAVITREAL METHOTREXATE INJECTION FOR THE TREATMENT AND PREVENTION OF PROLIFERATIVE VITREORETINOPATHY.

Patrick J HughesNeelakshi BhagatOrlando G Gonzalez-Martinez Marco A Zarbin

Published in: Retina (Philadelphia, Pa.) (2024)

Serial intravitreal MTX injection was associated with 90% single operation retinal reattachment rate in the setting of retinal detachment with proliferative vitreoretinopathy or retinal detachment at high risk of proliferative vitreoretinopathy.

Keyphrases

diabetic retinopathy
vascular endothelial growth factor
age related macular degeneration
ultrasound guided
high dose
endothelial cells
replacement therapy